| Financial Year |
March 31 2023 |
| Monetary Funds |
7,360,160,742.00 |
| Held-for-trading Financial Assets |
891,300.00 |
| Notes Receivable |
358,719,595.00 |
| Accounts Receivable |
258,332,855.00 |
| Advances to Suppliers |
259,962,004.00 |
| Other Receivables |
247,460,306.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,039,549,029.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
676,268,126.00 |
| Other Current Assets |
116,168,287.00 |
| Total Current Assets |
15,347,677,303.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,586,225,341.00 |
| Investment Properties |
-- |
| Fixed Assetes |
22,194,452,242.00 |
| Under-construction Projects |
1,265,086,447.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,293,606,514.00 |
| R&D expenses |
-- |
| Goodwill |
15,706,944.00 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
631,789,607.00 |
| Other Non-Current Assets |
388,581,044.00 |
| Sub-Total of Non-Current Assets |
37,906,692,201.00 |
| Total Assets |
53,254,369,504.00 |
| Short-Term Loans |
6,451,143,713.00 |
| Trading Financial liabilities |
4,350,120.00 |
| Notes Payable |
1,206,234,262.00 |
| Accounts Payable |
1,741,919,663.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
50,960,483.00 |
| Taxes Payable |
336,091,561.00 |
| Interest Payable |
-- |
| Dividend Payable |
49,968,000.00 |
| Other payables |
1,671,412,514.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,412,553,333.00 |
| Other Current Liabilities |
62,579,641.00 |
| Sub-Total of Current Liabilities |
17,617,290,006.00 |
| Long-term Loans |
12,029,794,561.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
599,917,831.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
845,211,925.00 |
| Deferred Income Tax Liabilities |
246,665,762.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,934,520,443.00 |
| Total Liabilities |
32,551,810,449.00 |
| Paid-In Capital(Or Share Stock) |
2,383,000,000.00 |
| Capital Surplus |
5,284,891,143.00 |
| Surplus Reserve |
1,029,743,982.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,825,777,287.00 |
| Minority Stockholder's Interest |
3,863,001,126.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,839,557,929.00 |
| Owner's Equity（Stockholder's Equity） |
20,702,559,055.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
53,254,369,504.00 |
